Monopar Therapeutics Inc
Price
FilingsNewest: 8-K, Results of operationsAug 12 →Insiders1 insider bought $104,925 in 1 open-market buy. 1 insider sold $343,889, 0 of 2 sales on a 10b5-1 plan.→HoldersJupiter Topco 19.5%Ra 9.9%BlackRock 5.2%→Financing →PeersClosest companies: BNTC, IMMX, SDEV→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$17.8Mlast 12 months
- Operating cash flow
- −$10.0Mlast 12 months
- Cash and equivalents
- $52.8Mat the last balance sheet
- Shares outstanding
- 6.7M shareson issue